| 11919921 |
Galactoside inhibitor of galectins |
Richard JOHNSSON, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg |
2024-03-05 |
| 11377464 |
Galactoside inhibitor of galectins |
Richard JOHNSSON, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg |
2022-07-05 |
| 10851114 |
2-oxothiatole compounds having activity as cPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders |
Berit Johansen, Marcel Sandberg, Inger-Reidun Aukrust, George Kokotos, Johan Evenäs +1 more |
2020-12-01 |
| 10774102 |
Galactoside inhibitor of galectins |
Richard JOHNSSON, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg |
2020-09-15 |
| 10730902 |
1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins |
Fredrik Zetterberg, Ulf Nilsson, Hakon Leffler, Anders PEDERSEN, Hans Schambye +1 more |
2020-08-04 |
| 10526360 |
Galactoside inhibitor of galectins |
Richard JOHNSSON, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg |
2020-01-07 |
| 10464964 |
Galactoside inhibitor of galectins |
Fredrik Zetterberg, Ulf Nilsson, Hakon Leffler, Richard JOHNSSON, Priya Verma |
2019-11-05 |
| 10150781 |
2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders |
Berit Johansen, Marcel Sanderberg, Inger-Reidun Aukrust, George Kokotos, Johan Evenäs +1 more |
2018-12-11 |
| 10011597 |
Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes |
Michael Rützler, Klaus Dreisch, Johan Evenäs, Joakim Larsson |
2018-07-03 |